ArticleACS ES&T water2025
Anabaenopeptin B Chlorination Degradation By-Products Retain Potent Carboxypeptidase B Inhibition.
Article in ACS ES&T water, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The release of anabaenopeptins (APs) into source freshwater from cyanobacteria harmful algal blooms (cHABs) has raised concerns due to their reported abundance and inhibitory activity toward carboxypeptidases (CP). This study aimed to determine if chlorination, a widely used drinking water treatment, of AP-A, AP-B, and AP-679 inactivates their ability to inhibit carboxypeptidases A (CPA) and B (CPB). Each chlorinate treated AP's degradation by-products (DBPs) were analyzed via high-resolution mass spectrometry (HRMS) to track structural changes. This analysis suggested that site-specific chlorination begins with tyrosine residues. The resulting DBPs for each AP were then tested with standard enzyme assays to observe inhibitory changes to CPA and CPB. It was observed that AP-B DBPs retained potent inhibition of CPB. The lack of chlorine efficacy in inactivating AP-B is attributed to the ureido group arginine being unaffected by chlorination. As cHABs continue to pose global risks to drinking water supplies, further research is needed on AP inactivation, AP removal by drinking water treatment processes, and the impact of CP inhibition on human health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.